Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 6/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.43 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29976289 | 0.90 | CYP2C19 (0.62) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 | |
| SCHEMBL11327432 | 0.90 | CYP2C19 (0.62) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 | |
| Acrylic Acid SCHEMBL9576773 | 0.89 | CYP2C9 (0.54) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 | |
| SCHEMBL10663388 | 0.88 | CYP2C9 (0.59) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 | |
| SCHEMBL8922674 | 0.86 | CYP2C9 (0.57) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 | |
| SCHEMBL2164224 | 0.86 | CYP2C19 (0.79) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 | |
| SCHEMBL29478058 | 0.85 | CYP2C9 (0.51) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 | |
| SCHEMBL225240 | 0.85 | CYP2C19 (0.55) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 | |
| SCHEMBL30241127 | 0.85 | CYP2C19 (0.55) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 | |
| SCHEMBL8851966 | 0.84 | CYP2C19 (0.67) | CYP2C19CYP2C9CYP3A4TSHRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042319-A1 | LAMINATE, METHOD FOR MANUFACTURING LAMINATE, AND TIRE | BRIDGESTONE CORPORATION (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4582251-A1 | LAMINATE, METHOD FOR MANUFACTURING LAMINATE, AND TIRE | BRIDGESTONE CORPORATION (JP) | 2025-07-09 | — | — | EP | disclosed |
| US-20240417532-A1 | CONDUCTIVE RESIN COMPOSITION | SAKATA INX CORPORATION (JP) | 2024-12-19 | — | — | US | disclosed |
| EP-4424769-A1 | CONDUCTIVE RESIN COMPOSITION | Sakata INX Corporation (JP) | 2024-09-04 | — | — | EP | disclosed |
| WO-2024166496-A1 | NON-PNEUMATIC TIRE | 株式会社ブリヂストン | 2024-08-15 | — | — | WO | disclosed |
| US-20240217270-A1 | NON-PNEUMATIC TIRE | BRIDGESTONE CORPORATION (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-4338981-A1 | NON-PNEUMATIC TIRE | BRIDGESTONE CORPORATION (JP) | 2024-03-20 | — | — | EP | disclosed |
| WO-2024048400-A1 | LAMINATE, METHOD FOR MANUFACTURING LAMINATE, AND TIRE | 株式会社ブリヂストン | 2024-03-07 | — | — | WO | disclosed |
| EP-4317166-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME, AND USE APPLICATION FOR SAME | Sumitomo Chemical Company Limited (JP) | 2024-02-07 | — | — | EP | disclosed |
| EP-0823435-A2 | Phosphites, process for producing the same and their use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-02-11 | — | — | EP | disclosed |
| EP-0251724-B1 | COMPOSITIONS CONTAINING BISPHENOL COMPOUNDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-10 | — | — | EP | disclosed |
| EP-0246766-B1 | THE STABILIZATION OF DYE IMAGES PRODUCED IN PHOTOGRAPHIC MATERIALS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1991-03-27 | — | — | EP | disclosed |
| US-4782011-A | COLOR PHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1988-11-01 | — | — | US | disclosed |
| US-4774274-A | BISPHENOL MONOACRYLATES OR MONOMETHACRYLATES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-09-27 | — | — | US | disclosed |
| US-4528108-A | Method for cooling internal combustion engine with an oleaginous coolant fluid composition | THE LUBRIZOL CORPORATION (US) | 1985-07-09 | — | — | US | disclosed |
| US-4307187-A | THIOSULFONIC ACIDS PREVENT HEAT FOG WHEN STORED, REDUCING AGENTS | FUJI PHOTO FILM CO., LTD. (JP) | 1981-12-22 | — | — | US | disclosed |
| US-4258129-A | IMPROVE GREEN SHELF LIFE | FUJI PHOTO FILM CO., LTD. (JP) | 1981-03-24 | — | — | US | disclosed |
| US-4211839-A | SILVER HALIDE AND ORGANIC SILVER SALT PREPARED IN AN IMINO COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1980-07-08 | — | — | US | disclosed |
| US-4188212-A | BEZNOTRIAZOLE | FUJI PHOTO FILM CO., LTD. (JP) | 1980-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | EBPL, ACSL6, ACSL3 | CYP2C19 1902/4885CYP2C9 1363/4885CYP3A4 1171/4885 |
| US-20260042319-A1 | LAMINATE, METHOD FOR MANUFACTURING LAMINATE, AND TIRE | TEX10, POT1, RAE1 | CYP2C19 4500/4885CYP2C9 4149/4885CYP3A4 2973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.